Harvard Bioscience, Inc. (HBIO)
USD 2.03
(-6.45%)
USD 2.03
(-6.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.02 Million | 1.15 Million | 1.26 Million | 9.33 Million | 8.04 Million | 2.34 Million |
| Net Income | -3.41 Million | -9.51 Million | -288 Thousand | -7.81 Million | -4.68 Million | -3.46 Million |
| Depreciation & Amortization | 6.99 Million | 7.57 Million | 7.62 Million | 7.63 Million | 7.73 Million | 7.88 Million |
| Deferred income taxes | 336 Thousand | -414 Thousand | -330 Thousand | -143 Thousand | -398 Thousand | -2.86 Million |
| Stock-based compensation | 5 Million | 4.41 Million | 4.16 Million | 3.64 Million | 3.03 Million | 3.04 Million |
| Change in working capital | 4.6 Million | 2.71 Million | -10.19 Million | 4.1 Million | 42 Thousand | -1.67 Million |
| Other non-cash items | 509 Thousand | -3.62 Million | 280 Thousand | 1.89 Million | 2.32 Million | -584 Thousand |
| Investing Cash Flow | -1.79 Million | -1.59 Million | -1.34 Million | -1.4 Million | -229 Thousand | -53.25 Million |
| Investments in PPE | -2.31 Million | -1.59 Million | -1.34 Million | -1.15 Million | -1.21 Million | -986 Thousand |
| Acquisitions | 512 Thousand | - | - | - | 1 Million | -52.25 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -11 Thousand | - | -150 Thousand | -250 Thousand | -15 Thousand | -16 Thousand |
| Financing Cash Flow | -12.13 Million | -2.83 Million | -252 Thousand | -7.96 Million | -7.62 Million | 53.05 Million |
| Debt repayment | -10.54 Million | -9.58 Million | -52 Thousand | -68.8 Million | -11.7 Million | -20.19 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.52 Million | -1.62 Million | -3.51 Million | -1.14 Million | -221 Thousand | - |
| Common Stock Issuance | 930 Thousand | 577 Thousand | 3.31 Million | - | -221 Thousand | 4.55 Million |
| Other Financing Activities | -2.52 Million | 9.42 Million | -3.51 Million | 61.98 Million | 4.74 Million | 68.69 Million |
| Accounts receivables | 810 Thousand | 4.78 Million | -4.29 Million | 3.1 Million | 468 Thousand | -2.79 Million |
| Accounts payables | 555 Thousand | -1.39 Million | -540 Thousand | 511 Thousand | -2.04 Million | 1.59 Million |
| Inventory | 1.52 Million | 252 Thousand | -5.86 Million | 413 Thousand | 3.26 Million | 2.55 Million |
| Other working capital | 1.71 Million | -917 Thousand | 505 Thousand | 77 Thousand | -1.63 Million | -3.03 Million |
| Cash at beginning of period | 4.5 Million | 7.82 Million | 8.31 Million | 8.33 Million | 8.17 Million | 5.73 Million |
| Cash at end of period | 4.28 Million | 4.5 Million | 7.82 Million | 8.31 Million | 8.33 Million | 8.17 Million |
| Capital Expenditure | -2.31 Million | -1.59 Million | -1.34 Million | -1.15 Million | -1.21 Million | -986 Thousand |
| Effect of forex changes on cash | -320 Thousand | -38 Thousand | -161 Thousand | 20 Thousand | -30 Thousand | 299 Thousand |
| Net cash flow / Change in cash | -225 Thousand | -3.31 Million | -496 Thousand | -18 Thousand | 162 Thousand | 2.44 Million |
| Free Cash Flow | 11.71 Million | -438 Thousand | -83 Thousand | 8.17 Million | 6.83 Million | 1.35 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.92 Million | -4.69 Million | -1.81 Million | -3.41 Million | -1.23 Million | -980 Thousand |
| Depreciation & Amortization | 1.75 Million | 1.73 Million | 1.77 Million | 6.99 Million | 1.77 Million | 1.72 Million |
| Deferred income taxes | 229 Thousand | 178 Thousand | 244 Thousand | 336 Thousand | 6000.00 | 141 Thousand |
| Stock-based compensation | 1.27 Million | 1.04 Million | 1.38 Million | 5 Million | 1.36 Million | 1.1 Million |
| Change in working capital | -1.57 Million | 1.7 Million | 2.38 Million | 4.6 Million | 3.59 Million | -83 Thousand |
| Other non-cash items | 5.86 Million | 3.39 Million | 333 Thousand | 509 Thousand | -1.13 Million | 1.65 Million |
| Investing Cash Flow | 458 Thousand | -225 Thousand | -1.06 Million | -1.79 Million | -401 Thousand | -625 Thousand |
| Investments in PPE | -966 Thousand | -720 Thousand | -1.06 Million | -2.31 Million | -401 Thousand | -625 Thousand |
| Acquisitions | - | - | -512 Thousand | 512 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 1.42 Million | 495 Thousand | - | - | - | - |
| Other Investing Activities | 1.27 Million | -75 Thousand | 512 Thousand | -11 Thousand | -184 Thousand | -108 Thousand |
| Financing Cash Flow | 177 Thousand | -1.05 Million | -4.11 Million | -12.13 Million | -2.75 Million | -2.37 Million |
| Debt repayment | - | -1.02 Million | -2.25 Million | -10.54 Million | -3.75 Million | -3.7 Million |
| Dividends payments | - | - | -481 Thousand | - | - | - |
| Common Stock Repurchased | -12 Thousand | -47 Thousand | 451 Thousand | -2.52 Million | - | -295 Thousand |
| Common Stock Issuance | 189 Thousand | 15 Thousand | 206 Thousand | 930 Thousand | - | 620 Thousand |
| Other Financing Activities | -12 Thousand | -47 Thousand | -2.04 Million | -2.52 Million | 1 Million | 1.32 Million |
| Accounts receivables | 2.75 Million | 704 Thousand | -941 Thousand | 810 Thousand | 1.81 Million | 855 Thousand |
| Accounts payables | -2.29 Million | 2.46 Million | -140 Thousand | 555 Thousand | 1.8 Million | -1.33 Million |
| Inventory | -1.13 Million | -617 Thousand | 1.35 Million | 1.52 Million | -225 Thousand | 690 Thousand |
| Other working capital | -902 Thousand | -848 Thousand | 2.11 Million | 1.71 Million | 190 Thousand | -296 Thousand |
| Cash at beginning of period | 4.25 Million | 4.28 Million | 5.34 Million | 4.5 Million | 4.34 Million | 3.78 Million |
| Cash at end of period | 4.04 Million | 4.25 Million | 4.28 Million | 4.28 Million | 5.34 Million | 4.32 Million |
| Capital Expenditure | -966 Thousand | -720 Thousand | -1.06 Million | -2.31 Million | -401 Thousand | -625 Thousand |
| Effect of forex changes on cash | 4000.00 | -151 Thousand | -183 Thousand | -320 Thousand | -211 Thousand | -17 Thousand |
| Net cash flow / Change in cash | -207 Thousand | -28 Thousand | -1.05 Million | -225 Thousand | 999 Thousand | 535 Thousand |
| Free Cash Flow | -1.81 Million | 683 Thousand | 3.24 Million | 11.71 Million | 3.96 Million | 2.92 Million |
BSBR
002150
JPNRF
PRN
7360
603421